ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $649,226 | -72.1% | 25,410 | -68.7% | 0.00% | -100.0% |
Q2 2023 | $2,325,088 | +325.4% | 81,070 | +255.6% | 0.00% | – |
Q1 2023 | $546,516 | +41.3% | 22,800 | 0.0% | 0.00% | – |
Q4 2022 | $386,688 | +14.4% | 22,800 | 0.0% | 0.00% | – |
Q3 2022 | $338,000 | -17.8% | 22,800 | -12.6% | 0.00% | – |
Q2 2022 | $411,000 | -41.6% | 26,100 | 0.0% | 0.00% | – |
Q1 2022 | $704,000 | -27.1% | 26,100 | 0.0% | 0.00% | – |
Q4 2021 | $966,000 | -22.5% | 26,100 | 0.0% | 0.00% | – |
Q3 2021 | $1,247,000 | +22.4% | 26,100 | -13.3% | 0.00% | – |
Q2 2021 | $1,019,000 | -18.0% | 30,100 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $1,243,000 | -4.8% | 30,100 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,306,000 | +89.0% | 30,100 | +87.0% | 0.00% | – |
Q3 2020 | $691,000 | -11.5% | 16,100 | -3.6% | 0.00% | – |
Q2 2020 | $781,000 | – | 16,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
Diametric Capital, LP | 26,130 | $667,621 | 0.28% |